March 14, 2023

In the video below you can find out and see exactly how TECVAYLI works. You can learn about the side effects and how to manage them.

March 09, 2023

A new molecule called FABP5 was found by myeloma researchers and targeting it with an inhibitor could slow myeloma growth.

March 07, 2023

Testing myeloma using a normal hip bone marrow biopsy compared to testing a large focal lesion can provide different results.

February 22, 2023

Elranatamab now has an Early Access Program and has Priority Review for FDA approval

February 16, 2023

Could kappa or lambda be better myeloma targets than BCMA?

February 16, 2023

Can CAR T treatment be given as an outpatient therapy?

February 12, 2023

Promoting equity across all levels of cancer care must be addressed from different sides of the problem.

February 07, 2023

Clinical trials are essential to advance knowledge in any disease. Yet getting the right people into clinical trials is still a haphazard process.

February 06, 2023

A new method (BloodFlow) was developed to increase the negative predictive value and showed an unprecedented sensitivity to detect MRD.

February 02, 2023

A recent study provided strong evidence for intensification of therapy in patients with high-risk myeloma determined by their genetic profile.